Skip to main content
Erschienen in: Endocrine 1/2019

01.06.2019 | Original Article

Fractalkine: an inflammatory chemokine elevated in subjects with polycystic ovary syndrome

verfasst von: İsmail Demi̇r, Aslı Guler, Pınar Alarslan, Ahmet Murat Isil, Ozge Ucman, Behnaz Aslanipour, Mehmet Calan

Erschienen in: Endocrine | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Fractalkine (FKN) is an inflammatory chemokine related to reproductive system and glucose metabolism. There is a link between FKN and steroidogenesis as FKN induces progesterone synthesis. Polycystic ovary syndrome (PCOS) is a common reproductive and metabolic disorder associated with low progesterone production and insulin resistance. We aimed to explore whether women with PCOS have any difference in FKN levels compared to women without PCOS. We also focused on determination of any association between FKN levels and hormonal-metabolic parameters in women with PCOS.

Methods

The current research was designed as a case–control study. Eighty subjects with PCOS and 80 age- and body mass index (BMI)-matched subjects with normal menstrual cycle were taken into the study. We measured circulating FKN levels via ELISA methods.

Results

Circulating FKN levels were higher in women with PCOS than controls (1.93 ± 0.61 vs. 1.22 ± 0.33 ng/ml, P< 0.001). FKN levels showed a positive correlation with body mass index (BMI), insulin resistance, inflammatory marker hs-CRP, total testosterone, and free-androgen index (FAI), whereas it showed a negative correlation with sex hormone-binding protein in women with PCOS. Linear regression analyses revealed that the link of FKN with BMI, insulin resistance, hs-CRP, and FAI was independent. Binary logistic regression analysis showed that the risk of having PCOS was associated with high levels of FKN.

Conclusions

Increased FKN levels related to insulin resistance, inflammation and androgens in women with PCOS. FKN may have an inter-related role in different pathophysiologic pathways of PCOS.
Literatur
1.
Zurück zum Zitat J.F. Bazan, K.B. Bacon, G. Hardiman, W. Wang, K. Soo, D. Rossi, D.R. Greaves, A. Zlotnik, T.J. Schall, A new class of membrane-bound chemokine with a CX3C motif. Nature 385, 640–644 (1997)CrossRef J.F. Bazan, K.B. Bacon, G. Hardiman, W. Wang, K. Soo, D. Rossi, D.R. Greaves, A. Zlotnik, T.J. Schall, A new class of membrane-bound chemokine with a CX3C motif. Nature 385, 640–644 (1997)CrossRef
2.
Zurück zum Zitat T. Imai, K. Hieshima, C. Haskell, M. Baba, M. Nagira, M. Nishimura, M. Kakizaki, S. Takagi, H. Nomiyama, T.J. Schall, O. Yoshie, Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 91, 521–530 (1997)CrossRef T. Imai, K. Hieshima, C. Haskell, M. Baba, M. Nagira, M. Nishimura, M. Kakizaki, S. Takagi, H. Nomiyama, T.J. Schall, O. Yoshie, Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 91, 521–530 (1997)CrossRef
3.
Zurück zum Zitat S. Goda, T. Imai, O. Yoshie, O. Yoneda, H. Inoue, Y. Nagano, T. Okazaki, H. Imai, E.T. Bloom, N. Domae, H. Umehara, CX3C-chemokine, fractalkine-enhanced adhesion of THP-1 cells to endothelial cells through integrin-dependent and -independent mechanisms. J. Immunol. 164, 4313–4320 (2000)CrossRefPubMed S. Goda, T. Imai, O. Yoshie, O. Yoneda, H. Inoue, Y. Nagano, T. Okazaki, H. Imai, E.T. Bloom, N. Domae, H. Umehara, CX3C-chemokine, fractalkine-enhanced adhesion of THP-1 cells to endothelial cells through integrin-dependent and -independent mechanisms. J. Immunol. 164, 4313–4320 (2000)CrossRefPubMed
4.
Zurück zum Zitat B.W. Wong, D. Wong, B.M. McManus, Characterization of fractalkine (CX3CL1) and CX3CR1 in human coronary arteries with native atherosclerosis, diabetes mellitus, and transplant vascular disease. Cardiovasc. Pathol. 11, 332–338 (2002)CrossRefPubMed B.W. Wong, D. Wong, B.M. McManus, Characterization of fractalkine (CX3CL1) and CX3CR1 in human coronary arteries with native atherosclerosis, diabetes mellitus, and transplant vascular disease. Cardiovasc. Pathol. 11, 332–338 (2002)CrossRefPubMed
5.
Zurück zum Zitat S. Huang, P. Zhao, L. Yang, Y. Chen, J. Yan, E. Duan, J. Qiao, Fractalkine is expressed in the human ovary and increases progesterone biosynthesis in human luteinised granulosa cells. Reprod. Biol. Endocrinol. 9, 95 (2011)CrossRefPubMedPubMedCentral S. Huang, P. Zhao, L. Yang, Y. Chen, J. Yan, E. Duan, J. Qiao, Fractalkine is expressed in the human ovary and increases progesterone biosynthesis in human luteinised granulosa cells. Reprod. Biol. Endocrinol. 9, 95 (2011)CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat J.K. Harrison, Y. Jiang, E.A. Wees, M.N. Salafranca, H.-X. Liang, L. Feng, L. Belardinelli, Inflammatory agents regulate in vivo expression of fractalkine in endothelial cells of the rat heart. J. Leukoc. Biol. 66, 937–944 (1999)CrossRefPubMed J.K. Harrison, Y. Jiang, E.A. Wees, M.N. Salafranca, H.-X. Liang, L. Feng, L. Belardinelli, Inflammatory agents regulate in vivo expression of fractalkine in endothelial cells of the rat heart. J. Leukoc. Biol. 66, 937–944 (1999)CrossRefPubMed
7.
Zurück zum Zitat P. Zhao, A. De, Z. Hu, J. Li, S.M. Mulders, M.D. Sollewijn Gelpke, E.-K. Duan, A.J.W. Hsueh, Gonadotropin stimulation of ovarian fractalkine expression and fractalkine augmentation of progesterone biosynthesis by luteinizing granulosa cells. Endocrinology 149, 2782–2789 (2008)CrossRefPubMedPubMedCentral P. Zhao, A. De, Z. Hu, J. Li, S.M. Mulders, M.D. Sollewijn Gelpke, E.-K. Duan, A.J.W. Hsueh, Gonadotropin stimulation of ovarian fractalkine expression and fractalkine augmentation of progesterone biosynthesis by luteinizing granulosa cells. Endocrinology 149, 2782–2789 (2008)CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Y.S. Lee, H. Morinaga, J.J. Kim, W. Lagakos, S. Taylor, M. Keshwani, G. Perkins, H. Dong, A.G. Kayali, I.R. Sweet, J. Olefsky, The fractalkine/CX3CR1 system regulates β cell function and insulin secretion. Cell 153, 413–425 (2013)CrossRefPubMedPubMedCentral Y.S. Lee, H. Morinaga, J.J. Kim, W. Lagakos, S. Taylor, M. Keshwani, G. Perkins, H. Dong, A.G. Kayali, I.R. Sweet, J. Olefsky, The fractalkine/CX3CR1 system regulates β cell function and insulin secretion. Cell 153, 413–425 (2013)CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Da Ehrmann, D.R. Liljenquist, K. Kasza, R. Azziz, R.S. Legro, M.N. Ghazzi, Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 91, 48–53 (2006)CrossRefPubMed Da Ehrmann, D.R. Liljenquist, K. Kasza, R. Azziz, R.S. Legro, M.N. Ghazzi, Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 91, 48–53 (2006)CrossRefPubMed
10.
Zurück zum Zitat A. Dunaif, Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr. Rev. 18, 774–800 (1997)PubMed A. Dunaif, Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr. Rev. 18, 774–800 (1997)PubMed
11.
Zurück zum Zitat R. Azziz, K.S. Woods, R. Reyna, T.J. Key, E.S. Knochenhauer, B.O. Yildiz, The prevalence and features of the polycystic ovary syndrome in an unselected population. J. Clin. Endocrinol. Metab. 89, 2745–2749 (2004)CrossRefPubMed R. Azziz, K.S. Woods, R. Reyna, T.J. Key, E.S. Knochenhauer, B.O. Yildiz, The prevalence and features of the polycystic ovary syndrome in an unselected population. J. Clin. Endocrinol. Metab. 89, 2745–2749 (2004)CrossRefPubMed
12.
Zurück zum Zitat W.A. March, V.M. Moore, K.J. Willson, D.I.W. Phillips, R.J. Norman, M.J. Davies, The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum. Reprod. 25, 544–551 (2010)CrossRefPubMed W.A. March, V.M. Moore, K.J. Willson, D.I.W. Phillips, R.J. Norman, M.J. Davies, The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum. Reprod. 25, 544–551 (2010)CrossRefPubMed
13.
14.
Zurück zum Zitat R. Rebar, H.L. Judd, S.S. Yen, J. Rakoff, G. Vandenberg, F. Naftolin, Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. J. Clin. Invest. 57, 1320–1329 (1976)CrossRefPubMedPubMedCentral R. Rebar, H.L. Judd, S.S. Yen, J. Rakoff, G. Vandenberg, F. Naftolin, Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. J. Clin. Invest. 57, 1320–1329 (1976)CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat S. Huang, Y. Pang, J. Yan, S. Lin, Y. Zhao, L. Lei, L. Yan, R. Li, C. Ma, J. Qiao, Fractalkine restores the decreased expression of StAR and progesterone in granulosa cells from patients with polycystic ovary syndrome. Sci. Rep. 6, 26205 (2016)CrossRefPubMedPubMedCentral S. Huang, Y. Pang, J. Yan, S. Lin, Y. Zhao, L. Lei, L. Yan, R. Li, C. Ma, J. Qiao, Fractalkine restores the decreased expression of StAR and progesterone in granulosa cells from patients with polycystic ovary syndrome. Sci. Rep. 6, 26205 (2016)CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum. Reprod. 19, 41–47 (2004)CrossRef Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum. Reprod. 19, 41–47 (2004)CrossRef
17.
Zurück zum Zitat D. Ferriman, J.D. Gallwey, Clinical assessment of body hair growth in women. J. Clin. Endocrinol. Metab. 21, 1440–1447 (1961)CrossRefPubMed D. Ferriman, J.D. Gallwey, Clinical assessment of body hair growth in women. J. Clin. Endocrinol. Metab. 21, 1440–1447 (1961)CrossRefPubMed
18.
Zurück zum Zitat M.K. Al Kindi, F.S. Al Essry, F.S. Al Essry, W.-A.S. Mula-Abed, Validity of serum testosterone, free androgen index, and calculated free testosterone in women with suspected hyperandrogenism. Oman Med. J. 27, 471–474 (2012)CrossRefPubMedPubMedCentral M.K. Al Kindi, F.S. Al Essry, F.S. Al Essry, W.-A.S. Mula-Abed, Validity of serum testosterone, free androgen index, and calculated free testosterone in women with suspected hyperandrogenism. Oman Med. J. 27, 471–474 (2012)CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat W.T. Friedewald, R.I. Levy, D.S. Fredrickson, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499–502 (1972)PubMed W.T. Friedewald, R.I. Levy, D.S. Fredrickson, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499–502 (1972)PubMed
20.
Zurück zum Zitat D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, R.C. Turner, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412–419 (1985)CrossRef D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, R.C. Turner, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412–419 (1985)CrossRef
21.
Zurück zum Zitat B. Geloneze, E.M. Repetto, S.R. Geloneze, M.A. Tambascia, M.N. Ermetice, The threshold value for insulin resistance (HOMA-IR) in an admixtured population. Diabetes Res. Clin. Pract. 72, 219–220 (2006)CrossRefPubMed B. Geloneze, E.M. Repetto, S.R. Geloneze, M.A. Tambascia, M.N. Ermetice, The threshold value for insulin resistance (HOMA-IR) in an admixtured population. Diabetes Res. Clin. Pract. 72, 219–220 (2006)CrossRefPubMed
22.
Zurück zum Zitat M. Reverchon, C. Ramé, M. Bertoldo, J. Dupont, Adipokines and the female reproductive tract. Int. J. Endocrinol. 2014, 1–10 (2014)CrossRef M. Reverchon, C. Ramé, M. Bertoldo, J. Dupont, Adipokines and the female reproductive tract. Int. J. Endocrinol. 2014, 1–10 (2014)CrossRef
23.
Zurück zum Zitat T. Kume, M. Calan, O. Yilmaz, G.U. Kocabas, P. Yesil, M. Temur, M. Bicer, O.G. Calan, A possible connection between tumor necrosis factor alpha and adropin levels in polycystic ovary syndrome. J. Endocrinol. Invest. 39, 747–754 (2016)CrossRefPubMed T. Kume, M. Calan, O. Yilmaz, G.U. Kocabas, P. Yesil, M. Temur, M. Bicer, O.G. Calan, A possible connection between tumor necrosis factor alpha and adropin levels in polycystic ovary syndrome. J. Endocrinol. Invest. 39, 747–754 (2016)CrossRefPubMed
24.
Zurück zum Zitat F. González, Inflammation in polycystic ovary syndrome: underpinning of insulin resistance and ovarian dysfunction. Steroids 77, 300–305 (2012)CrossRefPubMed F. González, Inflammation in polycystic ovary syndrome: underpinning of insulin resistance and ovarian dysfunction. Steroids 77, 300–305 (2012)CrossRefPubMed
25.
Zurück zum Zitat S. Sindhu, N. Akhter, H. Arefanian, A.A. Al-Roub, S. Ali, A. Wilson, A. Al-Hubail, S. Al-Beloushi, S. Al-Zanki, R. Ahmad, Increased circulatory levels of fractalkine (CX3CL1) are associated with inflammatory chemokines and cytokines in individuals with type-2 diabetes. J. Diabetes Metab. Disord. 16, 15 (2017)CrossRefPubMedPubMedCentral S. Sindhu, N. Akhter, H. Arefanian, A.A. Al-Roub, S. Ali, A. Wilson, A. Al-Hubail, S. Al-Beloushi, S. Al-Zanki, R. Ahmad, Increased circulatory levels of fractalkine (CX3CL1) are associated with inflammatory chemokines and cytokines in individuals with type-2 diabetes. J. Diabetes Metab. Disord. 16, 15 (2017)CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat R. Shah, C.C. Hinkle, J.F. Ferguson, N.N. Mehta, M. Li, L. Qu, Y. Lu, M.E. Putt, R.S. Ahima, M.P. Reilly, Fractalkine is a novel human adipochemokine associated with type 2 diabetes. Diabetes 60, 1512–1518 (2011)CrossRefPubMedPubMedCentral R. Shah, C.C. Hinkle, J.F. Ferguson, N.N. Mehta, M. Li, L. Qu, Y. Lu, M.E. Putt, R.S. Ahima, M.P. Reilly, Fractalkine is a novel human adipochemokine associated with type 2 diabetes. Diabetes 60, 1512–1518 (2011)CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat L. Franco, F.M.K. Williams, S. Trofimov, G. Surdulescu, T. Spector, G. Livshits, Elevated plasma fractalkine levels are associated with higher levels of IL-6, Apo-B, LDL-C and insulin, but not with body composition in a large female twin sample. Metabolism 62, 1081–1087 (2013)CrossRefPubMed L. Franco, F.M.K. Williams, S. Trofimov, G. Surdulescu, T. Spector, G. Livshits, Elevated plasma fractalkine levels are associated with higher levels of IL-6, Apo-B, LDL-C and insulin, but not with body composition in a large female twin sample. Metabolism 62, 1081–1087 (2013)CrossRefPubMed
28.
Zurück zum Zitat T. Ebert, J. Hindricks, S. Kralisch, U. Lossner, B. Jessnitzer, J. Richter, M. Blüher, M. Stumvoll, M. Fasshauer, Serum levels of fractalkine are associated with markers of insulin resistance in gestational diabetes. Diabet. Med. 31, 1014–1017 (2014)CrossRefPubMed T. Ebert, J. Hindricks, S. Kralisch, U. Lossner, B. Jessnitzer, J. Richter, M. Blüher, M. Stumvoll, M. Fasshauer, Serum levels of fractalkine are associated with markers of insulin resistance in gestational diabetes. Diabet. Med. 31, 1014–1017 (2014)CrossRefPubMed
29.
Zurück zum Zitat W.L. Breslin, C.A. Johnston, K. Strohacker, K.C. Carpenter, T.R. Davidson, J.P. Moreno, J.P. Foreyt, B.K. McFarlin, Obese Mexican American children have elevated MCP-1, TNF-, monocyte concentration, and dyslipidemia. Pediatrics 129, e1180–e1186 (2012)CrossRefPubMed W.L. Breslin, C.A. Johnston, K. Strohacker, K.C. Carpenter, T.R. Davidson, J.P. Moreno, J.P. Foreyt, B.K. McFarlin, Obese Mexican American children have elevated MCP-1, TNF-, monocyte concentration, and dyslipidemia. Pediatrics 129, e1180–e1186 (2012)CrossRefPubMed
30.
Zurück zum Zitat D. Sirois-Gagnon, A. Chamberland, S. Perron, D. Brisson, D. Gaudet, C. Laprise, Association of common polymorphisms in the fractalkine receptor (CX3CR1) with obesity. Obesity 19, 222–227 (2011)CrossRefPubMed D. Sirois-Gagnon, A. Chamberland, S. Perron, D. Brisson, D. Gaudet, C. Laprise, Association of common polymorphisms in the fractalkine receptor (CX3CR1) with obesity. Obesity 19, 222–227 (2011)CrossRefPubMed
Metadaten
Titel
Fractalkine: an inflammatory chemokine elevated in subjects with polycystic ovary syndrome
verfasst von
İsmail Demi̇r
Aslı Guler
Pınar Alarslan
Ahmet Murat Isil
Ozge Ucman
Behnaz Aslanipour
Mehmet Calan
Publikationsdatum
01.06.2019
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 1/2019
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-019-01972-3

Weitere Artikel der Ausgabe 1/2019

Endocrine 1/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.